{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T15:17:29Z","timestamp":1783178249141,"version":"3.54.6"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015569","name":"Canadian Consortium on Neurodegeneration in Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015569","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010785","name":"Canada First Research Excellence Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010785","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000023","name":"Government of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000023","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015751","name":"CQDM","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015751","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008582","name":"McGill University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008582","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000864","name":"The Michael J Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","award":["MJFF-025378"],"award-info":[{"award-number":["MJFF-025378"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Methods"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ymeth.2026.05.001","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T15:49:21Z","timestamp":1777996161000},"page":"41-54","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A high-content imaging workflow to screen for molecules that reduce cellular uptake of \u03b1-synuclein preformed fibrils"],"prefix":"10.1016","volume":"252","author":[{"given":"Wolfgang E.","family":"Reintsch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea I.","family":"Krahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanshuai","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Nguyen-Renou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol X.-Q.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Shlaifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Pfeifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward A.","family":"Fon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Durcan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymeth.2026.05.001_b0005","unstructured":"Lewy, F., Paralysis agitans. Handbuch der Neurologie, Spezielle Neurologie I. Vol. 3. 1912, Berlin: Julius Springer. 920-933."},{"key":"10.1016\/j.ymeth.2026.05.001_b0010","series-title":"Contribution a l'\u00e9tude de l'anatomie pathologique du Locus Niger de Soemmering avec quelques d\u00e9ductions relative \u00e0 la pathog\u00e9nie des troubles du tonus muscularaire et de la maladie de Parkinson","author":"Tretiakoff","year":"1919"},{"issue":"11","key":"10.1016\/j.ymeth.2026.05.001_b0015","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26115405","article-title":"Alpha-synuclein pathology in synucleinopathies: mechanisms, biomarkers, and therapeutic challenges","volume":"26","author":"Arias-Carrion","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.ymeth.2026.05.001_b0020","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/s41591-024-03469-7","article-title":"Toward a biological definition of neuronal and glial synucleinopathies","volume":"31","author":"Soto","year":"2025","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.ymeth.2026.05.001_b0025","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/s41593-019-0423-2","article-title":"Lewy pathology in Parkinson's disease consists of crowded organelles and lipid membranes","volume":"22","author":"Shahmoradian","year":"2019","journal-title":"Nat. Neurosci."},{"issue":"2","key":"10.1016\/j.ymeth.2026.05.001_b0030","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s12035-012-8280-y","article-title":"The Lewy body in Parkinson's disease and related neurodegenerative disorders","volume":"47","author":"Wakabayashi","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ymeth.2026.05.001_b0035","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3389\/fnins.2019.00028","article-title":"Alpha-synuclein: a multifunctional player in exocytosis, endocytosis, and vesicle recycling","volume":"13","author":"Huang","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ymeth.2026.05.001_b0040","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1146\/annurev-pathol-031920-092547","article-title":"The membrane interactions of synuclein: physiology and pathology","volume":"16","author":"Runwal","year":"2021","journal-title":"Annu. Rev. Pathol."},{"issue":"5321","key":"10.1016\/j.ymeth.2026.05.001_b0045","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson's disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.ymeth.2026.05.001_b0050","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng0298-106","article-title":"Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease","volume":"18","author":"Kruger","year":"1998","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.ymeth.2026.05.001_b0055","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ana.10795","article-title":"The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia","volume":"55","author":"Zarranz","year":"2004","journal-title":"Ann. Neurol."},{"issue":"9440","key":"10.1016\/j.ymeth.2026.05.001_b0060","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(04)17103-1","article-title":"Alpha-synuclein locus duplication as a cause of familial Parkinson's disease","volume":"364","author":"Chartier-Harlin","year":"2004","journal-title":"Lancet"},{"issue":"9440","key":"10.1016\/j.ymeth.2026.05.001_b0065","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/S0140-6736(04)17104-3","article-title":"Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease","volume":"364","author":"Ibanez","year":"2004","journal-title":"Lancet"},{"issue":"5646","key":"10.1016\/j.ymeth.2026.05.001_b0070","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1090278","article-title":"alpha-Synuclein locus triplication causes Parkinson's disease","volume":"302","author":"Singleton","year":"2003","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.ymeth.2026.05.001_b0075","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcab223","article-title":"Midbrain organoids with an SNCA gene triplication model key features of synucleinopathy","volume":"3","author":"Mohamed","year":"2021","journal-title":"Brain Commun"},{"key":"10.1016\/j.ymeth.2026.05.001_b0080","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3389\/fneur.2018.00295","article-title":"Alpha-synuclein: from early synaptic dysfunction to neurodegeneration","volume":"9","author":"Ghiglieri","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ymeth.2026.05.001_b0085","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.toxlet.2020.01.019","article-title":"Endoplasmic reticulum stress, an important factor in the development of Parkinson's disease","volume":"324","author":"Mou","year":"2020","journal-title":"Toxicol. Lett."},{"issue":"1","key":"10.1016\/j.ymeth.2026.05.001_b0090","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neulet.2005.11.012","article-title":"Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology","volume":"396","author":"Braak","year":"2006","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.ymeth.2026.05.001_b0095","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ymeth.2026.05.001_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105687","article-title":"The roles of connectivity and neuronal phenotype in determining the pattern of alpha-synuclein pathology in Parkinson's disease","volume":"168","author":"Henderson","year":"2022","journal-title":"Neurobiol. Dis."},{"issue":"15","key":"10.1016\/j.ymeth.2026.05.001_b0105","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22158338","article-title":"The prion-like spreading of alpha-synuclein in Parkinson's disease: update on models and hypotheses","volume":"22","author":"Jan","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ymeth.2026.05.001_b0110","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13024-020-00368-6","article-title":"Initiation and propagation of alpha-synuclein aggregation in the nervous system","volume":"15","author":"Hijaz","year":"2020","journal-title":"Mol. Neurodegener."},{"issue":"23","key":"10.1016\/j.ymeth.2026.05.001_b0115","doi-asserted-by":"crossref","first-page":"6593","DOI":"10.1111\/febs.15674","article-title":"Molecular events underlying the cell-to-cell transmission of alpha-synuclein","volume":"288","author":"Choi","year":"2021","journal-title":"FEBS J."},{"issue":"7794","key":"10.1016\/j.ymeth.2026.05.001_b0120","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41586-020-1984-7","article-title":"Discriminating alpha-synuclein strains in Parkinson's disease and multiple system atrophy","volume":"578","author":"Shahnawaz","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ymeth.2026.05.001_b0125","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.852003","article-title":"Alpha-synuclein targeting therapeutics for parkinson's disease and related synucleinopathies","volume":"13","author":"Menon","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ymeth.2026.05.001_b0130","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3389\/fnmol.2019.00299","article-title":"Targeting alpha-synuclein as a therapy for Parkinson's disease","volume":"12","author":"Fields","year":"2019","journal-title":"Front. Mol. Neurosci."},{"issue":"6109","key":"10.1016\/j.ymeth.2026.05.001_b0135","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.1227157","article-title":"Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice","volume":"338","author":"Luk","year":"2012","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.ymeth.2026.05.001_b0140","doi-asserted-by":"crossref","DOI":"10.3390\/cells12071083","article-title":"Alpha-synuclein preformed fibrils bind to beta-neurexins and impair beta-neurexin-mediated presynaptic organization","volume":"12","author":"Feller","year":"2023","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.ymeth.2026.05.001_b0145","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3233\/JPD-171248","article-title":"Best practices for generating and using alpha-synuclein pre-formed fibrils to model Parkinson's disease in rodents","volume":"8","author":"Polinski","year":"2018","journal-title":"J. Parkinsons Dis."},{"issue":"8","key":"10.1016\/j.ymeth.2026.05.001_b0150","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1111\/jnc.15967","article-title":"Neuroanatomical and cognitive biomarkers of alpha-synuclein propagation in a mouse model of synucleinopathy prior to onset of motor symptoms","volume":"168","author":"Tullo","year":"2024","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymeth.2026.05.001_b0155","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.nbd.2015.06.003","article-title":"Intrastriatal injection of pre-formed mouse alpha-synuclein fibrils into rats triggers alpha-synuclein pathology and bilateral nigrostriatal degeneration","volume":"82","author":"Paumier","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ymeth.2026.05.001_b0160","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.neuroscience.2021.11.009","article-title":"Co-registration of imaging modalities (MRI, CT and PET) to perform frameless stereotaxic robotic injections in the common marmoset","volume":"480","author":"Kwan","year":"2022","journal-title":"Neuroscience"},{"issue":"Pt B","key":"10.1016\/j.ymeth.2026.05.001_b0165","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.nbd.2017.03.007","article-title":"Internalization, axonal transport and release of fibrillar forms of alpha-synuclein","volume":"109","author":"Bieri","year":"2018","journal-title":"Neurobiol. Dis."},{"issue":"5","key":"10.1016\/j.ymeth.2026.05.001_b0170","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1042\/BST20220204","article-title":"Propagation of Parkinson's disease by extracellular vesicle production and secretion","volume":"50","author":"Shippey","year":"2022","journal-title":"Biochem. Soc. Trans."},{"issue":"3","key":"10.1016\/j.ymeth.2026.05.001_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111102","article-title":"Rapid macropinocytic transfer of alpha-synuclein to lysosomes","volume":"40","author":"Bayati","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymeth.2026.05.001_b0180","article-title":"Studying Pre-formed fibril induced alpha-synuclein accumulation in primary embryonic mouse midbrain dopamine neurons","volume":"162","author":"Er","year":"2020","journal-title":"J. Vis. Exp."},{"issue":"2","key":"10.1016\/j.ymeth.2026.05.001_b0185","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/brain\/awad298","article-title":"MerTK is a mediator of alpha-synuclein fibril uptake by human microglia","volume":"147","author":"Dorion","year":"2024","journal-title":"Brain"},{"key":"10.1016\/j.ymeth.2026.05.001_b0190","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2024.1470171","article-title":"Intercellular transmission of alpha-synuclein","volume":"17","author":"Wu","year":"2024","journal-title":"Front. Mol. Neurosci."},{"issue":"10","key":"10.1016\/j.ymeth.2026.05.001_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107742","article-title":"Alpha-synuclein, autophagy-lysosomal pathway, and Lewy bodies: Mutations, propagation, aggregation, and the formation of inclusions","volume":"300","author":"Bayati","year":"2024","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.ymeth.2026.05.001_b0200","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1038\/s41593-024-01775-4","article-title":"Modeling Parkinson's disease pathology in human dopaminergic neurons by sequential exposure to alpha-synuclein fibrils and proinflammatory cytokines","volume":"27","author":"Bayati","year":"2024","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ymeth.2026.05.001_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2019.101581","article-title":"Deploying human pluripotent stem cells to treat central nervous system disorders: facts, challenges and realising the potential","volume":"41","author":"Allsopp","year":"2019","journal-title":"Stem Cell Res."},{"issue":"7","key":"10.1016\/j.ymeth.2026.05.001_b0210","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22073381","article-title":"Current state-of-the-art and unresolved problems in using human induced pluripotent stem cell-derived dopamine neurons for Parkinson's disease drug development","volume":"22","author":"Antonov","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.ymeth.2026.05.001_b0215","doi-asserted-by":"crossref","DOI":"10.3390\/mps4030050","article-title":"A multistep workflow to evaluate newly generated iPSCs and their ability to generate different cell types","volume":"4","author":"Chen","year":"2021","journal-title":"Methods Protoc"},{"key":"10.1016\/j.ymeth.2026.05.001_b0220","unstructured":"Chen, X., et al., Induction of Dopaminergic or Cortical neuronal progenitors from iPSCs. Zenodo, 2019(V2.0)."},{"key":"10.1016\/j.ymeth.2026.05.001_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2022.102806","article-title":"Generation of homozygous PRKN, PINK1 and double PINK1\/PRKN knockout cell lines from healthy induced pluripotent stem cells using CRISPR\/Cas9 editing","volume":"62","author":"Chen","year":"2022","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.ymeth.2026.05.001_b0230","unstructured":"Maneca, D.-L., et al., Production of Recombinant \u03b1-Synuclein Monomers and Preformed Fibrils (PFFs). Zenodo, 2022(V3.0)."},{"key":"10.1016\/j.ymeth.2026.05.001_b0235","unstructured":"Del Cid Pellitero, E., et al., Quality Control Characterization of \u03b1-Synuclein Preformed Fibrils (PFFs). Zenodo, 2019(V2.0)."},{"key":"10.1016\/j.ymeth.2026.05.001_b0240","unstructured":"Reintsch, W., A. Krahn Roldan, and T.M. Durcan, High Content Imaging, Analysis and Data Management. Zenodo, 2020(V1.0)."},{"key":"10.1016\/j.ymeth.2026.05.001_b0245","unstructured":"Krahn, A., et al., Uptake of a-Synuclein Preformed Fibrils (PFFs) in Dopaminergic Neural Progenitor Cells. Zenodo, 2020(V1.0)."},{"issue":"2","key":"10.1016\/j.ymeth.2026.05.001_b0250","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A simple statistical parameter for use in evaluation and validation of high throughput screening assays","volume":"4","author":"Zhang","year":"1999","journal-title":"J. Biomol. Screen."},{"issue":"6228","key":"10.1016\/j.ymeth.2026.05.001_b0255","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/340035a0","article-title":"Expression of a large family of POU-domain regulatory genes in mammalian brain development","volume":"340","author":"He","year":"1989","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.ymeth.2026.05.001_b0260","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1083\/jcb.143.7.1883","article-title":"Aggresomes: a cellular response to misfolded proteins","volume":"143","author":"Johnston","year":"1998","journal-title":"J. Cell Biol."},{"issue":"32","key":"10.1016\/j.ymeth.2026.05.001_b0265","doi-asserted-by":"crossref","first-page":"13482","DOI":"10.1074\/jbc.M117.780296","article-title":"Selective imaging of internalized proteopathic alpha-synuclein seeds in primary neurons reveals mechanistic insight into transmission of synucleinopathies","volume":"292","author":"Karpowicz","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"33","key":"10.1016\/j.ymeth.2026.05.001_b0270","doi-asserted-by":"crossref","first-page":"E3138","DOI":"10.1073\/pnas.1301440110","article-title":"Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds","volume":"110","author":"Holmes","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.ymeth.2026.05.001_b0275","doi-asserted-by":"crossref","DOI":"10.1038\/s41421-020-00222-5","article-title":"Heparan sulfate assists SARS-CoV-2 in cell entry and can be targeted by approved drugs in vitro","volume":"6","author":"Zhang","year":"2020","journal-title":"Cell Discovery"},{"issue":"1","key":"10.1016\/j.ymeth.2026.05.001_b0280","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1083\/jcb.106.1.213","article-title":"The L2\/HNK-1 carbohydrate of neural cell adhesion molecules is involved in cell interactions","volume":"106","author":"Kunemund","year":"1988","journal-title":"J. Cell Biol."},{"issue":"5","key":"10.1016\/j.ymeth.2026.05.001_b0285","doi-asserted-by":"crossref","first-page":"C896","DOI":"10.1152\/ajpcell.00050.2022","article-title":"Coreceptor functions of cell surface heparan sulfate proteoglycans","volume":"322","author":"Hayashida","year":"2022","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.ymeth.2026.05.001_b0290","doi-asserted-by":"crossref","unstructured":"Bar, H. and A. Zweifach, Z' Does Not Need to Be > 0.5. SLAS Discov, 2020. 25(9): p. 1000-1008.","DOI":"10.1177\/2472555220942764"},{"issue":"1","key":"10.1016\/j.ymeth.2026.05.001_b0295","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1186\/s12859-021-04344-9","article-title":"CellProfiler 4: improvements in speed, utility and usability","volume":"22","author":"Stirling","year":"2021","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.ymeth.2026.05.001_b0300","unstructured":"Dahlin, J.L., et al., Interference and Artifacts in High-content Screening, in Assay Guidance Manual, S. Markossian, et al., Editors. 2004: Bethesda (MD)."},{"key":"10.1016\/j.ymeth.2026.05.001_b0305","first-page":"99","article-title":"Profile of bosutinib and its clinical potential in the treatment of chronic myeloid leukemia","volume":"6","author":"Amsberg","year":"2013","journal-title":"Onco Targets Ther"},{"issue":"4","key":"10.1016\/j.ymeth.2026.05.001_b0310","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1634\/theoncologist.2008-0261","article-title":"Vandetanib (ZD6474), a dual inhibitor of vascular endothelial growth factor receptor (VEGFR) and epidermal growth factor receptor (EGFR) tyrosine kinases: current status and future directions","volume":"14","author":"Morabito","year":"2009","journal-title":"Oncologist"},{"issue":"7","key":"10.1016\/j.ymeth.2026.05.001_b0315","article-title":"The dual role of c-src in cell-to-cell transmission of alpha-synuclein","volume":"21","author":"Choi","year":"2020","journal-title":"EMBO Rep."},{"issue":"2","key":"10.1016\/j.ymeth.2026.05.001_b0320","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s13311-021-01017-6","article-title":"Pharmacological inhibition of brain EGFR activation by a BBB-penetrating inhibitor, AZD3759, attenuates alpha-synuclein pathology in a mouse model of alpha-synuclein propagation","volume":"18","author":"Tavassoly","year":"2021","journal-title":"Neurotherapeutics"},{"issue":"4","key":"10.1016\/j.ymeth.2026.05.001_b0325","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/jps.20792","article-title":"Lysosomal sequestration of amine-containing drugs: analysis and therapeutic implications","volume":"96","author":"Kaufmann","year":"2007","journal-title":"J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.ymeth.2026.05.001_b0330","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173771","article-title":"Lysosomal adaptation: how cells respond to lysosomotropic compounds","volume":"12","author":"Lu","year":"2017","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ymeth.2026.05.001_b0335","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.nbd.2011.01.029","article-title":"Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission","volume":"42","author":"Alvarez-Erviti","year":"2011","journal-title":"Neurobiol. Dis."},{"issue":"20","key":"10.1016\/j.ymeth.2026.05.001_b0340","doi-asserted-by":"crossref","first-page":"6838","DOI":"10.1523\/JNEUROSCI.5699-09.2010","article-title":"Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival","volume":"30","author":"Emmanouilidou","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ymeth.2026.05.001_b0345","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.681369","article-title":"Targeting of lysosomal pathway genes for Parkinson's disease modification: insights from cellular and animal models","volume":"12","author":"Abe","year":"2021","journal-title":"Front. Neurol."},{"issue":"12","key":"10.1016\/j.ymeth.2026.05.001_b0350","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.4103\/NRR.NRR-D-23-01175","article-title":"Na+\/K+-ATPase: ion pump, signal transducer, or cytoprotective protein, and novel biological functions","volume":"19","author":"Huang","year":"2024","journal-title":"Neural Regen. Res."},{"issue":"19","key":"10.1016\/j.ymeth.2026.05.001_b0355","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.15252\/embj.201591397","article-title":"\u03b1-synuclein assemblies sequester neuronal \u03b13-Na+\/K+-ATPase and impair Na+ gradient","volume":"34","author":"Shrivastava","year":"2015","journal-title":"EMBO J."},{"issue":"10","key":"10.1016\/j.ymeth.2026.05.001_b0360","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1111\/febs.15124","article-title":"The interactome of stabilized alpha-synuclein oligomers and neuronal proteins","volume":"287","author":"van Diggelen","year":"2020","journal-title":"FEBS J."},{"key":"10.1016\/j.ymeth.2026.05.001_b0365","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ceb.2021.02.006","article-title":"From the inside out: Ion fluxes at the centre of endocytic traffic","volume":"71","author":"Chadwick","year":"2021","journal-title":"Curr. Opin. Cell Biol."},{"issue":"7","key":"10.1016\/j.ymeth.2026.05.001_b0370","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00819-20","article-title":"Identification of antiviral drug candidates against SARS-CoV-2 from FDA-Approved Drugs","volume":"64","author":"Jeon","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ymeth.2026.05.001_b0375","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.virol.2022.05.004","article-title":"Identification of potential COVID-19 treatment compounds which inhibit SARS Cov2 prototypic, delta and omicron variant infection","volume":"572","author":"Kumar","year":"2022","journal-title":"Virology"}],"container-title":["Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046202326001131?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046202326001131?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T14:43:48Z","timestamp":1783176228000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1046202326001131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":75,"alternative-id":["S1046202326001131"],"URL":"https:\/\/doi.org\/10.1016\/j.ymeth.2026.05.001","relation":{"has-preprint":[{"id-type":"doi","id":"10.64898\/2025.12.22.695981","asserted-by":"object"}]},"ISSN":["1046-2023"],"issn-type":[{"value":"1046-2023","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A high-content imaging workflow to screen for molecules that reduce cellular uptake of \u03b1-synuclein preformed fibrils","name":"articletitle","label":"Article Title"},{"value":"Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymeth.2026.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}